EGFR-IN-194
EGFR-IN-194 is a potent EGFR tyrosine kinase inhibitor with an IC50 of 54.3 nM against human EGFR. EGFR-IN-194 induces apoptosis, inhibits migration in cancer cells, selectively promotes invasion in cancer cells, and exhibits antiproliferative effects across multiple cancer cell lines. EGFR-IN-194 can be used for the research of prostate adenocarcinoma, non-small cell lung carcinoma, breast carcinoma, chronic myeloid leukemia.
For research use only. We do not sell to patients.
- Formula: C28H29FN4O2S
- Molecular Weight:504.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
EGFR 54.3 nM (IC50) |
In Vitro
EGFR-IN-194 (compound 24) (1-100 μM; 48 h) potently inhibits proliferation of PC-3, A549, MCF-7, and K562 cancer cells with IC50 values of 3.18 μM, 9.69 μM, 43.51 μM, and 71.18 μM, respectively, while sparing NIH3T3 noncancerous cells[1].
EGFR-IN-194 (5 μM; 24 h for PC-3; 10 μM; 24 h for A549) induces mitochondrial depolarization in PC-3 and A549 cells, and triggeres apoptosis in PC-3 and A549 cells[1].
EGFR-IN-194 (5 μM; up to 48 h for PC-3; 10 μM; up to 48 h for A549) inhibited migration of PC-3 and A549 cells, as shown by reduced wound closure[1].
EGFR-IN-194 (~18 h) promoted invasion of PC-3 cells and inhibited invasion of A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:K562, PC-3, MCF-7, A549, NIH3T3
-
Concentration:1-100 μM
-
Incubation Time:48 h
-
Result:Inhibited proliferation of K562 cells with an IC50 of 71.18 μM; inhibited proliferation of PC-3 cells with an IC50 of 3.18 μM; inhibited proliferation of MCF-7 cells with an IC50 of 43.51 μM; inhibited proliferation of A549 cells with an IC50 of 9.69 μM; showed minimal cytotoxicity toward NIH3T3 cells with an IC50 > 100 μM.
-
Cell Line:PC-3, A549
-
Concentration:5 μM (PC-3); 10 μM (A549)
-
Incubation Time:24 h (PC-3); 24 h (A549)
-
Result:Induced early and late apoptosis in PC-3 cells, characterized by condensed/fragmented nuclei; induced intense nuclear fragmentation and increased late apoptotic cells in A549 cells.
-
Cell Line:PC-3, A549
-
Concentration:5 μM (PC-3); 10 μM (A549)
-
Incubation Time:48 h
-
Result:Moderately inhibited PC-3 migration at 24 h and significantly reduced wound closure at 48 h; severely inhibited A549 migration at 48 h compared to controls.
Chemical Information
-
Molecular Weight 504.62
-
Formula C28H29FN4O2S
-
SMILES
O=C(NC1=CC=C(F)C=C1)CSC2=NN=C(N2CC3=CC=CC=C3)COC4=C(C(C)C)C=CC(C)=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)